Key Record Dates
ClinicalTrials.gov Identifier: | NCT02436993 |
---|---|
Brief Title: | Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or Bevacizumab |
First Submitted : | April 20, 2015 |
First Submitted that Met QC Criteria : | May 4, 2015 |
First Posted : | May 7, 2015 (Estimate) |
Last Update Submitted that Met QC Criteria : | June 30, 2020 |
Last Update Posted : | July 2, 2020 |